Astrana Health shareholders approve amended equity plan; Weili Dai receives nearly 50% withheld votes

Astrana Health, Inc.

Stockholders approved increase of 2,000,000 shares under 2024 Equity Incentive Plan (total 4,100,000 shares reserved).
Term of 2024 Plan extended to March 25, 2035.
All nine director nominees elected; Weili Dai received 19,196,569 withheld vs 18,977,644 for (approx. 50% withheld).
Ernst & Young LLP ratified as independent auditor for fiscal 2025 (42,631,420 for, 260,880 against).
Advisory vote on executive compensation passed: 34,713,926 for, 3,370,998 against.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.